Propensity-Matched Comparisons of Clinical Outcomes After Transapical or Transfemoral Transcatheter Aortic Valve Replacement | Zendy

Eugene H. Blackstone | Zendy; Rakesh M. Suri | Zendy; Jeevanantham Rajeswaran | Zendy; Vasilis Babaliaros | Zendy; Pamela S. Douglas | Zendy; William F. Fearon | Zendy; D. Craig Miller | Zendy; Rebecca T. Hahn | Zendy; Samir Kapadia | Zendy; Ajay J. Kirtane | Zendy; Susheel Kodali | Zendy; Michael J. Mack | Zendy; Wilson Y. Szeto | Zendy; Vinod H. Thourani | Zendy; E. Murat Tuzcu | Zendy; Mathew Williams | Zendy; Jodi J. Akin | Zendy; Martin B. Leon | Zendy; Lars G. Svensson | Zendy

Open Access

Propensity-Matched Comparisons of Clinical Outcomes After Transapical or Transfemoral Transcatheter Aortic Valve Replacement

Author(s) -

Eugene H. Blackstone,

Rakesh M. Suri,

Jeevanantham Rajeswaran,

Vasilis Babaliaros,

Pamela S. Douglas,

William F. Fearon,

D. Craig Miller,

Rebecca T. Hahn,

Samir Kapadia,

Ajay J. Kirtane,

Susheel Kodali,

Michael J. Mack,

Wilson Y. Szeto,

Vinod H. Thourani,

E. Murat Tuzcu,

Mathew Williams,

Jodi J. Akin,

Martin B. Leon,

Lars G. Svensson

Publication year - 2015

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.114.012525

Subject(s) - medicine , propensity score matching , valve replacement , adverse effect , cardiology , stroke (engine) , aortic valve , surgery , regurgitation (circulation) , stenosis , mechanical engineering , engineering

The higher risk of adverse outcomes after transapical (TA) versus transfemoral (TF) transcatheter aortic valve replacement (TAVR) could be attributable to TA-TAVR being an open surgical procedure or to clinical differences between TA- and TF-TAVR patients. We compared outcomes after neutralizing patient differences using propensity score matching.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research